Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population

Journal of Endocrinological Investigation

Volumn 31, Issue 12, 2008, Pages 1086-1091

  Wang, Z L ^a   Xia, B ^a   Shrestha, U ^a   Jiang, L ^a   Ma, C W ^a   Chen, Q ^b   Chen, H ^a   Hu, Z G ^a  

^a WUHAN UNIVERSITY   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Adiponectin gene; Metabolic syndrome; Non alcohotic fatty liver disease; Polymorphism

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHINESE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; RADIOIMMUNOASSAY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 63049122519     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345657     Document Type: Article

References (38)

1. Haluzík M, Parízková J, Haluzík MM. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 2004, 53: 123-9.
2. Valenti L, Pracanzani AL, Dongiovanni P, et al. Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 2002, 122: 274-80.
3. Crespo J, Cayon, Fernandez-Gil P, et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001, 34: 1158-63.
4. Iwamoto N, Ogawa Y, Kajihara S, et al. Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver. Clin Chim Acta 2001, 314: 85-91.
5. Staiger H, Ischritter O, Machann J, Thamer C, et al. Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 2003, 11: 368-72.
6. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86: 1930-5.
7. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002, 87: 2764-9.
8. Kishida K, Nagaretani H, Kondo H, et al. Disturbed secretion of mutant adiponectin associated with the metabolic syndrome. Biochem Biophys Res Commun 2003, 306: 286-92.
9. Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23: 85-9.
10. Lonardo A, Bellini M, Tartoni P, Tondelli E. The bright liver syndrome. Prevalence and determinants of a 'bright' liver echopattern. Ital J Gastroenterol Hepatol 1997, 29: 351-6.
11. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991, 43: 26-31.
12. Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association. Diagnostic criteria of nonalcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 2003, 11: 71.
13. Fatty Liver and Alcoholic Liver Disease Study Group, Chinese Liver Disease Association. Diagnostic criteria of alcoholic liver disease. Zhonghua Gan Zang Bing Za Zhi 2003, 11: 72.
14. Jinfeng T, Ying W, Qidi W, et al. Relationship between adiponectin concentration and adiposity. Chin J Endocrinol Metab 2003, 19: 166-8.
15. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412-9.
16. Lewontin RC. The interaction of selection and linkage 1. General considerations: heterotic models. Genetics 1964, 49: 49-67.
17. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001, 50: 1844-50.
18. Schindhelm RK, Diamant M, Dekker JM, et al. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006, 22: 437-43.
19. Haffner SM. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity (Silver Spring) 2006, 14 (Suppl 3): 121S-7S.
20. Schindhelm RK, Dekker JM, Nijpels G, et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 2007, 191: 391-6.
21. Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004, 68: 975-81.
22. Stumvoll M, Tschritter O, Fritsche A, et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 2002, 51: 37-41.
23. Katsuda Y, Asano A. Murase Y, et al. Association of genetic variation of the adiponectin gene with body fat distribution and carotid atherosclerosis in Japanese obese subjects. J Atheroscler Thromb 2007, 14: 19-26.
24. Hara K, Boutin P, Mori Y, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Janpanese population. Diabetes 2002, 51: 536-40.
25. Yang WS, Tsou PL, Lee WJ, et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med 2003, 81: 428-34.
26. Ukkola O, Ravuasin E, Jacobson P, et al. Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism 2003, 52: 881-4.
27. Menzaghi C, Ercolino T, Di Paola R, et al. A haplotype in the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002, 51: 2306-12.
28. Vasseur F, Helbecque N, Dina C, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and axon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002, 11: 2607-14.
29. Nakatani K, Noma K, Nishioka J, et al. Adiponectin gene variation associates with the increasing risk of type 2 diabetes in non-diabetic Japanese subjects. Int J Mol Med 2005, 15: 173-7.
30. Jang Y, Lee JH, Chae JS, et al. Association of the 276G->T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans. Am J Clin Nutr 2005, 82: 760-7.
31. Jang Y, Lee JH, Kim OY, et al. The SNP276G>T polymorphism in the adiponectin (ACDC) gene is more strongly associated with insulin resistance and cardiovascular disease risk than SNP45T>G in nonobese/ nondiabetic Korean men independent of abdominal adiposity and circulating plasma adiponectin. Metabolism 2006, 55: 59-66.
32. Filippi E, Sentinalli F, Trischitta V, et al. Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet 2004, 12: 199-205.
33. Takahashi M, Arita Y, Yamagata K, et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Ins J Obes Relat Metab Disord 2000, 24: 861-8.
34. Manzaghi C, Ercolino T, Salvemini L, et al. Multigenic control of serum adiponectin levels: evidence for a role of the APM1 gene and a locus on 14q13. Physiol Genomics 2004, 19: 170-4.
35. Fredriksson J, Carlsson E, Orho-Melander M, Groop L, Ridderstråle M. Polymorphism in the adiponectin gene influences adiponectin expression levels in visceral fat in obese subjects. Int J Obes (Lond) 2006, 30: 226-32.
36. Mousavinasab F, Tahtinen T, Jokelainen J, et al. Effect of the Pro12Ala polymorphism of the PPAR92 gene on serum adiponectin changes. Endocrine 2005, 27: 307-9.
37. González-Sánchez JL, Martínez-Calatrava MJ, Martínez-Larrad MT, et al. Interaction of the -308G/A Promoter Polymorphism of the Tumor Necrosis factor-alpha gene with single-nucleotide polymorphism 45 of the adiponectin gene: effect on serum adiponectin concentrations in a Spanish population. Clin Chem 2006, 52: 97-103.
38. Lonardo A, Bellini M, Tartoni P, Tondelli E. The bright liver syndrome. Prevalence and determinants of a 'bright' liver echopattern. Ital J Gastroenterol Hapatol 1997, 29: 351-6.